Ignite Creation Date:
2025-12-25 @ 4:41 AM
Ignite Modification Date:
2026-03-05 @ 5:42 AM
Study NCT ID:
NCT02543918
Status:
COMPLETED
Last Update Posted:
2017-01-06
First Post:
2015-09-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of the Immune Response to Vaccines and Ixekizumab (LY2439821) in Healthy Participants
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-09
Start Date Type:
None
Primary Completion Date:
2015-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-12
Completion Date Type:
ACTUAL
First Submit Date:
2015-09-04
First Submit QC Date:
None
Study First Post Date:
2015-09-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-11-09
Results First Submit QC Date:
None
Results First Post Date:
2017-01-06
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-11-09
Last Update Post Date:
2017-01-06
Last Update Post Date Type:
ESTIMATED